Article: P09 DARPin® molecule MP0250, a new antiangiogenic drug in multiple myeloma: An in vitro and in vivo study

€2.42

SKU: product-article-16346 Category: General

Description

Description

P09 DARPin® molecule MP0250, a new antiangiogenic drug in multiple myeloma: An in vitro and in vivo study

Top

Article: P09 DARPin® molecule MP0250, a new antiangiogenic drug in multiple myeloma: An in vitro and in vivo study

Description

Related products

Article: Highlights in squamous cell carcinoma of the head and neck

Article: Calendar of events

1 year access Online Belgian Journal of Hematology (BJH)

Article: Highlights in gynaecological cancers